TY - JOUR
T1 - Genetic associations with valvular calcification and aortic stenosis
AU - Thanassoulis, George
AU - Campbell, Catherine Y
AU - Owens, David S
AU - Smith, J Gustav
AU - Smith, Albert V
AU - Peloso, Gina M
AU - Kerr, Kathleen F
AU - Pechlivanis, Sonali
AU - Budoff, Matthew J
AU - Harris, Tamara B
AU - Malhotra, Rajeev
AU - O'Brien, Kevin D
AU - Kamstrup, Pia R
AU - Nordestgaard, Børge G
AU - Tybjaerg-Hansen, Anne
AU - Allison, Matthew A
AU - Aspelund, Thor
AU - Criqui, Michael H
AU - Heckbert, Susan R
AU - Hwang, Shih-Jen
AU - Liu, Yongmei
AU - Sjogren, Marketa
AU - van der Pals, Jesper
AU - Kälsch, Hagen
AU - Mühleisen, Thomas W
AU - Nöthen, Markus M
AU - Cupples, L Adrienne
AU - Caslake, Muriel
AU - Di Angelantonio, Emanuele
AU - Danesh, John
AU - Rotter, Jerome I
AU - Sigurdsson, Sigurdur
AU - Wong, Quenna
AU - Erbel, Raimund
AU - Kathiresan, Sekar
AU - Melander, Olle
AU - Gudnason, Vilmundur
AU - O'Donnell, Christopher J
AU - Post, Wendy S
AU - CHARGE Extracoronary Calcium Working Group
PY - 2013/2/7
Y1 - 2013/2/7
N2 - BACKGROUND: Limited information is available regarding genetic contributions to valvular calcification, which is an important precursor of clinical valve disease. METHODS: We determined genomewide associations with the presence of aortic-valve calcification (among 6942 participants) and mitral annular calcification (among 3795 participants), as detected by computed tomographic (CT) scanning; the study population for this analysis included persons of white European ancestry from three cohorts participating in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (discovery population). Findings were replicated in independent cohorts of persons with either CT-detected valvular calcification or clinical aortic stenosis. RESULTS: One SNP in the lipoprotein(a) (LPA) locus (rs10455872) reached genomewide significance for the presence of aortic-valve calcification (odds ratio per allele, 2.05; P = 9.0×10-10), a finding that was replicated in additional white European, African-American, and Hispanic-American cohorts (P<0.05 for all comparisons). Genetically determined Lp(a) levels, as predicted by LPA genotype, were also associated with aortic-valve calcification, supporting a causal role for Lp(a). In prospective analyses, LPA genotype was associated with incident aortic stenosis (hazard ratio per allele, 1.68; 95% confidence interval [CI], 1.32 to 2.15) and aortic-valve replacement (hazard ratio, 1.54; 95% CI, 1.05 to 2.27) in a large Swedish cohort; the association with incident aortic stenosis was also replicated in an independent Danish cohort. Two SNPs (rs17659543 and rs13415097) near the proinflammatory gene IL1F9 achieved genomewide significance for mitral annular calcification (P = 1.5×10-8 and P = 1.8×10 -8, respectively), but the findings were not replicated consistently. CONCLUSIONS: Genetic variation in the LPA locus, mediated by Lp(a) levels, is associated with aorticvalve calcification across multiple ethnic groups and with incident clinical aortic stenosis. (Funded by the National Heart, Lung, and Blood Institute and others.)
AB - BACKGROUND: Limited information is available regarding genetic contributions to valvular calcification, which is an important precursor of clinical valve disease. METHODS: We determined genomewide associations with the presence of aortic-valve calcification (among 6942 participants) and mitral annular calcification (among 3795 participants), as detected by computed tomographic (CT) scanning; the study population for this analysis included persons of white European ancestry from three cohorts participating in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (discovery population). Findings were replicated in independent cohorts of persons with either CT-detected valvular calcification or clinical aortic stenosis. RESULTS: One SNP in the lipoprotein(a) (LPA) locus (rs10455872) reached genomewide significance for the presence of aortic-valve calcification (odds ratio per allele, 2.05; P = 9.0×10-10), a finding that was replicated in additional white European, African-American, and Hispanic-American cohorts (P<0.05 for all comparisons). Genetically determined Lp(a) levels, as predicted by LPA genotype, were also associated with aortic-valve calcification, supporting a causal role for Lp(a). In prospective analyses, LPA genotype was associated with incident aortic stenosis (hazard ratio per allele, 1.68; 95% confidence interval [CI], 1.32 to 2.15) and aortic-valve replacement (hazard ratio, 1.54; 95% CI, 1.05 to 2.27) in a large Swedish cohort; the association with incident aortic stenosis was also replicated in an independent Danish cohort. Two SNPs (rs17659543 and rs13415097) near the proinflammatory gene IL1F9 achieved genomewide significance for mitral annular calcification (P = 1.5×10-8 and P = 1.8×10 -8, respectively), but the findings were not replicated consistently. CONCLUSIONS: Genetic variation in the LPA locus, mediated by Lp(a) levels, is associated with aorticvalve calcification across multiple ethnic groups and with incident clinical aortic stenosis. (Funded by the National Heart, Lung, and Blood Institute and others.)
U2 - 10.1056/NEJMoa1109034
DO - 10.1056/NEJMoa1109034
M3 - Journal article
C2 - 23388002
SN - 0028-4793
VL - 368
SP - 503
EP - 512
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 6
ER -